… The early use of an anticancer agent as maintenance therapy after disease stabilization or
… new treatment paradigm in NSCLC. Maintenance therapy can extend first‐line treatment and …

… Non–small cell lung cancer (NSCLC) is often diagnosed at later stages when treatment
options are limited. Maintenance therapy may prolong the time to disease progression and …

… Lung cancer is the most common cancer worldwide with non-small cell lung cancer (NSCLC), …
lung cancer: maintenance treatment or early second-line? Oncologist 2009;14:137–47. 5. …

… of maintenance therapy with either a continuation or a switch strategy in the treatment of
non–small-cell lung cancer … reporting RCTs comparing maintenance therapy and placebo or …

… SMALL-CELL LUNG carcinoma (SCLC) accounts for approximately 20% of lung cancers.
Combination chemotherapy with or without chest irradiation achieves high response rates and …

… cell lung cancer (NSCLC) is the leading cause of cancer death … Maintenance therapy is a
treatment strategy that has been … response to initial therapy after treatment with platinum-based …

… Lung cancer is the leading cause of cancer mortality in the … related to lung cancer worldwide.1,
2 Non-small cell lung cancer (… stage disease when the treatment is palliative. Platinum-…

… treatment regimen (switch maintenance). Several agents, both chemotherapeutic and targeted,
have been tested as maintenance treatments… have evaluated maintenance treatment and …

… role of maintenance treatment for patients with advanced non-small cell lung cancer (NSCLC) …
use of non-cross-resistant drug (switch maintenance or early second-line therapy) or the …

… established for the treatment of certain hematologic malignancies, maintenance therapy
has … a treatment paradigm for advanced non–small-cell lung cancer. Maintenance therapy, …